ici 204,219 has been researched along with Carcinoma, Renal Cell in 1 studies
zafirlukast: a leukotriene D4 receptor antagonist
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
Excerpt | Relevance | Reference |
---|---|---|
" Intriguingly, long-term use of zafirlukast decreases cancer risk and leukotriene receptor antagonists inhibit tumor growth, but the mechanisms still remain unexplored." | 1.72 | Zafirlukast Induces VHL- and HIF-2α-Dependent Oxidative Cell Death in 786-O Clear Cell Renal Carcinoma Cells. ( Smith, S; van Wijk, SJL; Wolf, C, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Wolf, C | 1 |
Smith, S | 1 |
van Wijk, SJL | 1 |
1 other study available for ici 204,219 and Carcinoma, Renal Cell
Article | Year |
---|---|
Zafirlukast Induces VHL- and HIF-2α-Dependent Oxidative Cell Death in 786-O Clear Cell Renal Carcinoma Cells.
Topics: Basic Helix-Loop-Helix Transcription Factors; Carcinoma, Renal Cell; Cell Death; Cell Line, Tumor; G | 2022 |